DSIP: adverse events and evidence limits
The inspected abstract describes intravenous DSIP in 16 chronic-insomnia patients over five laboratory nights. [1]
It reports sleep outcomes rather than adverse-event counts; clinical incidence cannot be derived from this abstract. [1]
What the studies reported
| Effect | Model or participants | How often or as described | Source |
|---|---|---|---|
| Adverse events | 16 patients with chronic insomnia, intravenous, five laboratory nights | The abstract reports sleep outcomes rather than adverse-event counts; clinical incidence cannot be derived from it | [1] |
References
- F Bes et al. (1992). Effects of Delta Sleep-Inducing Peptide on Sleep of Chronic Insomniac Patients. 10.1159/000118919.